Key Highlights:
- Qivalis plans to distribute its newly licensed token using a B2B2X model via banks, exchanges, and payment service providers.
- Issuance remains subject to European Union Markets in Crypto-Assets (MiCA) rules and Dutch central bank (DNB) regulatory requirements.
- Before token trading or public offering begins, Qivalis must finalize regulatory notifications and publish a detailed white paper outlining technical features, obligations, and risks.
Qivalis Outlines Distribution Strategy via B2B2X Model
Following its regulatory licensing milestones, token issuer Qivalis has laid out its intended path to market, focusing on broad institutional distribution. The company plans to deploy the token through an indirect framework commonly referred to as a B2B2X model. Under this structure, Qivalis will act solely as the primary issuer of the digital asset, relying on a network of eligible partners to supply the distribution channels required to reach end users.
Targeted distribution partners include credit institutions, digital asset exchanges, payment service providers, and market-infrastructure participants. While Qivalis has outlined the specific categories of counterparties eligible to participate in the rollout, the overall size of the consortium does not definitively indicate which specific firms will ultimately list or offer the asset to their retail or institutional clients, nor does it guarantee a precise launch date for public availability.
Regulatory Pre-Issuance Steps Under the MiCA Framework
Bringing the asset to market requires strict adherence to European standards. Under Article 48 of the European Union’s Markets in Crypto-Assets (MiCA) regulation, an entity seeking to offer an electronic money token (EMT) or admit it to trading must generally hold formal authorization as an electronic money institution or a credit institution, unless specific legal exemptions apply. In addition to licensing, issuers must formally notify regulators and publish a comprehensive white paper prior to any commercial rollout.
In accordance with De Nederlandsche Bank (DNB) guidance governing EMT issuance, Qivalis is mandated to notify the Dutch central bank of its intent to issue the token and provide the regulatory body with the final white paper. Qivalis has underscored that obtaining its operational license represents only one component of the broader compliance roadmap, with the formal token generation and release remaining subject to all outstanding MiCA operational requirements.
White Paper Disclosures and the Path to Market
The impending white paper serves as the foundational disclosure document for both market regulators and prospective holders. It must deliver an exhaustive breakdown of the issuer’s corporate structure, the token’s technical architecture, the technology stack deployed, and any relevant technological or market risks. Crucially, the documentation will detail the specific rights and legal obligations granted to token holders, providing prospective buyers with transparent product specifics that go far beyond the initial announcement of the firm’s license acquisition.
Under MiCA Article 51, the process of white-paper notification is legally distinguished from regulatory approval; national competent authorities are prohibited from requiring ex-ante approval of EMT white papers prior to their publication. Consequently, the publication of the document alongside formal regulatory notification represents the immediate next step for Qivalis as it prepares for issuance through its partner infrastructure.
Why This Matters
The progression of Qivalis under the MiCA regime illustrates the practical implementation of the European Union’s unified digital asset rules. For institutional crypto issuers, the transition from acquiring a financial license to executing an actual public launch highlights the layered compliance demands imposed on stablecoins and electronic money tokens in Europe. The reliance on a B2B2X model also signals a strategic push to embed regulated digital assets within traditional banking and established fintech rails rather than depending on direct-to-consumer issuance, setting a clear operational precedent for subsequent EMT projects targeting EU markets.
Frequently Asked Questions
What is the B2B2X distribution model adopted by Qivalis?
The B2B2X (business-to-business-to-x) model means that Qivalis will focus strictly on minting and issuing the underlying token, while authorized intermediary businesses—such as banks, licensed crypto exchanges, and payment service providers—will handle user-facing distribution and onboarding for end customers.
Does obtaining a license automatically allow Qivalis to start trading?
No. Under MiCA Article 48 and DNB guidance, holding an institutional license is only one phase of the process. Qivalis must also notify the appropriate regulatory authority of its intent to launch and publish a fully compliant white paper detailing the asset’s risks, rights, and technical infrastructure before offering the token to the public or listing it on trading venues.
Do European regulators need to approve the token white paper before it is published?
No. According to MiCA Article 51, regulatory authorities do not require prior approval of an EMT white paper before it is made public. However, the issuer is legally required to submit and publish the document in compliance with all regulatory disclosure standards.
